HeartSciences Inc.
HSCS | NASDAQ
$4.68
-$0.52 (-10.00%)
At close: Sep 21, 2026, 4:00 PM ET
$4.41
-$0.27 (-5.81%)
Pre-market:
Sep 22, 2026, 4:25 AM ET
Market Data
Market Cap $11.23M
Enterprise Value $-15.8M
Beta 1.86
Average Volume 2.3M
Shares Outstanding (Diluted) 3.67M
Shares Change YoY 181.46%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US42254E3027
Price Performance
Price Change 1M 63.1%
Price Change 3M 70.2%
Price Change 6M 89.5%
Price Change YTD 49.0%
Price Change 1Y 27.5%
Price Change 3Y -89.4%
Price Change 5Y -97.8%
1M CAGR (ann.) 160.0%
1Y CAGR (ann.) 50.3%
5Y CAGR (ann.) N/A
All-Time CAGR -55.9%
Valuation
PE Ratio -1.46
Forward PE N/A
PEG Ratio -0.02
Forward PEG 0.06
PS Ratio 2,236.44
Forward PS 3.20
PB Ratio -4.97
P/FCF Ratio -0.01
P/Adj. FCF Ratio -0.00
P/OCF Ratio -0.01
EV/Sales -3,495.25
EV/EBIT 1.67
EV/EBITDA 1.67
EV/FCF 0.01
Earnings Yield -68.4%
FCF Yield -13104.3%
Adj. FCF Yield -20426.6%
Financial Health
Net Cash $26.18M
Total Debt $4M
Cash & Short-Term Investments $29.91M
Total Assets $3.74M
Current Ratio 0.12
Quick Ratio -71.42
Debt / Equity Ratio -1.97
Debt / EBITDA -0.42
Debt / FCF -0.00
OCF / Debt -330.71
Interest Coverage -11.78
Altman Z-Score -41.92
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -2908.8%
Operating Profit Margin -209733.1%
EBITDA Margin -209670.0%
Net Profit Margin -227024.2%
FCF Margin -29306837.3%
Adj. FCF Margin -45682735.2%
SBC / Revenue 16375897.9%
SBC Impact (per share) -55.9%
Returns
Return on Assets -274.5%
Return on Equity -816.3%
Return on Invested Capital -480.8%
Return on Capital Employed 499.9%
Return on Tangible Assets 0.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 32.3%
Revenue CAGR 5Y -27.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 88.6%
EPS CAGR 5Y 71.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y -147.7%
FCF CAGR 5Y -97.1%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3
Price Target Upside -35.9%
Cash Flow
Operating Cash Flow $-1.32B
Free Cash Flow $-1.32B
Adj. Free Cash Flow $-2.06B
FCF Per Share -$360.97
OCF Per Share -$360.96
OCF/S Ratio -29305871.7%
Income Statement
Revenue $4.52K
Gross Profit $-131.45K
Operating Income $-9.48M
EBITDA $-9.47M
Net Income $-10.26M
EPS (Diluted) -$3.20
Revenue / Employee $322.79
Profit / Employee $-732.8K
Employees 14
Add to Watchlist
Select watchlists to add or remove HSCS